Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

NCT04722848 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
ALL, Adult
Philadelphia-Positive ALL

Interventions

DRUG: Ponatinib + Blinatumomab
DRUG: Chemotherapy + Imatinib

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto